Press release
30.10.2017 To the attention of interested persons NAMMD position in response to recent press allegations The National Agency for Medicines […]
Important notification
17.10.2017 To the attention of interested persons Information for sponsors of clinical trials regarding the electronic submission of SUSARs to […]
Important notification
17.10.2017 To the attention of interested persons Information for marketing authorization holders (MAHs) regarding alternative arrangements for electronic submission of […]
Important notification
17.10.2017 To the attention of interested persons The NAMMD would like to inform about the organization in Romania of a […]
Press release
10.10.2017 To the attention of interested persons Countdown to launch of new EudraVigilance System: final preparations for change-over to new […]
Press release
06.10.2017 To the attention of interested persons EMA press release: PRAC recommends modified-release paracetamol be removed from market (update: 29 […]
Press release
25.09.2017 To the attention of interested persons EMA concludes review of human factor VIII medicines authorised in EU download document […]
Press release
11.09.2017 To the attention of interested persons EMA press release: PRAC recommends modified-release paracetamol be removed from market download document […]
Press release
07.09.2017 To the attention of interested persons PRAC confirms its previous conclusion on risk of inhibitor development with factor VIII […]
Press release
16.08.2017 To the attention of interested persons EMA seeks views of public during its safety review of valproate Registration opens […]